Cargando…

New Insights into the Pathogenesis and Treatment Strategies in IgA Nephropathy

BACKGROUND: Immunoglobulin A nephropathy (IgAN) is the most common form of primary glomerulonephritis worldwide. It is defined by mesangial IgA deposition, with consequent mesangial cell proliferation, inflammation, and tubulointerstitial fibrosis. SUMMARY: Approximately 30% of affected patients wil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scionti, Katrin, Molyneux, Karen, Selvaskandan, Haresh, Barratt, Jonathan, Cheung, Chee Kay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677740/ https://www.ncbi.nlm.nih.gov/pubmed/36751267 http://dx.doi.org/10.1159/000519973

Ejemplares similares

New strategies and perspectives on managing IgA nephropathy
por: Selvaskandan, Haresh, et al.
Publicado: (2019)

New insights into the pathogenesis of IgA nephropathy
por: Yeo, See Cheng, et al.
Publicado: (2017)

Monitoring Immune Responses in IgA Nephropathy: Biomarkers to Guide Management
por: Selvaskandan, Haresh, et al.
Publicado: (2020)

The Non-Coding RNA Landscape in IgA Nephropathy—Where Are We in 2021?
por: Pawluczyk, Izabella Z. A., et al.
Publicado: (2021)

A Pilot Study to Predict Risk of IgA Nephropathy Progression Based on miR-204 Expression
por: Pawluczyk, Izabella, et al.
Publicado: (2021)

An Update on the Current State of Management and Clinical Trials for IgA Nephropathy
por: Cheung, Chee Kay, et al.
Publicado: (2021)

Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy
por: Kim, Min Jeong, et al.
Publicado: (2016)

MicroRNAs: a new avenue to understand, investigate and treat immunoglobulin A nephropathy?
por: Selvaskandan, Haresh, et al.
Publicado: (2018)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Special Issue: New Insights into the Pathogenesis and Therapies of IgA Nephropathy
por: Suzuki, Hitoshi, et al.
Publicado: (2022)

IgA nephropathy: a perspective for 2021
por: Floege, Jürgen, et al.
Publicado: (2021)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

New developments in the genetics, pathogenesis, and therapy of IgA nephropathy
por: Magistroni, Riccardo, et al.
Publicado: (2015)

The Emerging Role of Pathogenesis of IgA Nephropathy
por: Wu, Meng-Yu, et al.
Publicado: (2018)

IgA Nephropathy Genetic Risk Score to Estimate the Prevalence of IgA Nephropathy in UK Biobank
por: Sukcharoen, Kittiya, et al.
Publicado: (2020)

The contribution of a proliferation-inducing ligand (APRIL) and other TNF superfamily members in pathogenesis and progression of IgA nephropathy
por: Yeo, See Cheng, et al.
Publicado: (2023)

IgA Nephropathy: Current Treatment and New Insights
por: Petrou, Dimitra, et al.
Publicado: (2023)

Aberrantly Glycosylated IgA1 as a Factor in the Pathogenesis of IgA Nephropathy
por: Tanaka, Mototsugu, et al.
Publicado: (2011)

Challenges in IgA Nephropathy Management: An Era of Complement Inhibition
por: Tesař, Vladimir, et al.
Publicado: (2023)

The Role of Immune Modulation in Pathogenesis of IgA Nephropathy
por: Chang, Sheng, et al.
Publicado: (2020)

IgA nephropathy pathogenesis and therapy: Review & updates
por: Habas, Elmukhtar, et al.
Publicado: (2022)

Why Target the Gut to Treat IgA Nephropathy?
por: Barratt, Jonathan, et al.
Publicado: (2020)

Identification of IgA autoantibodies targeting mesangial cells redefines the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Recurrence of IgA nephropathy after kidney transplantation: experience from the Swiss transplant cohort study
por: Jäger, Cédric, et al.
Publicado: (2022)

The pathogenesis of COVID-19-induced IgA nephropathy and IgA vasculitis: A systematic review
por: Farooq, Hareem, et al.
Publicado: (2021)

Targeting the Endothelin A Receptor in IgA Nephropathy
por: Kohan, Donald E., et al.
Publicado: (2023)

Biomarkers for IgA nephropathy on the basis of multi-hit pathogenesis
por: Suzuki, Hitoshi
Publicado: (2018)

Mucosal Immune System Dysregulation in the Pathogenesis of IgA Nephropathy
por: Kano, Toshiki, et al.
Publicado: (2022)

IgA Nephropathy: Current Understanding and Perspectives on Pathogenesis and Targeted Treatment
por: Du, Yating, et al.
Publicado: (2023)

The role of mononuclear phagocyte system in IgA nephropathy: pathogenesis and prognosis
por: Liu, Yiwen, et al.
Publicado: (2023)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

Abnormal IgD and IgA1 O-glycosylation in hyperimmunoglobulinaemia D and periodic fever syndrome
por: de Wolff, Jacob F., et al.
Publicado: (2009)

Experimental IgA nephropathy
Publicado: (1979)

Sulodexide in IgA nephropathy
Publicado: (2013)

T lymphocytes in IgA nephropathy
por: Tang, Yuyan, et al.
Publicado: (2020)

International Physicians Delphi Survey: Managing Patients With IgA Nephropathy
por: Floege, Jürgen, et al.
Publicado: (2022)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
por: Papasotiriou, Marios, et al.
Publicado: (2022)

Renal abnormalities in rheumatoid arthritis: an insight on IgA nephropathy
por: Prata, Ana R, et al.
Publicado: (2021)

Role of Epstein-Barr Virus in Pathogenesis and Racial Distribution of IgA Nephropathy
por: Zachova, Katerina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l0hi5os7qmemvbutsp5guu2t24